Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
NCT06327451
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma, IDH-wildtype
Interventions
DRUG:
Atorvastatin 20mg
Sponsor
Tianjin Medical University General Hospital